SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-11-004721
Filing Date
2011-05-06
Accepted
2011-05-06 16:18:42
Documents
11
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2203470z10-q.htm 10-Q 589656
2 EXHIBIT 10.1 a2203470zex-10_1.htm EX-10.1 740156
3 EXHIBIT 31.1 a2203470zex-31_1.htm EX-31.1 7914
4 EXHIBIT 31.2 a2203470zex-31_2.htm EX-31.2 7928
5 EXHIBIT 32.2 a2203470zex-32_2.htm EX-32.2 4764
  Complete submission text file 0001047469-11-004721.txt   8685535

Data Files

Seq Description Document Type Size
6 EX-101.INS vrtx-20110331.xml EX-101.INS 757031
7 EX-101.SCH vrtx-20110331.xsd EX-101.SCH 122454
8 EX-101.CAL vrtx-20110331_cal.xml EX-101.CAL 95758
9 EX-101.LAB vrtx-20110331_lab.xml EX-101.LAB 1513748
10 EX-101.PRE vrtx-20110331_pre.xml EX-101.PRE 636304
11 EX-101.DEF vrtx-20110331_def.xml EX-101.DEF 410947
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 11819787
SIC: 2834 Pharmaceutical Preparations